Clinical Trial Update: Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL [Phase 1]

View source ↗

Summary

OC-1 therapy is being studied in a Phase 1 trial to assess safety and efficacy in relapsed/refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• OC-1 therapy

Snippet

Sponsor: OneChain Immunotherapeutics | Conditions: T-cell Acute Lymphoblastic Leukemia, Lymphoblastic T-Cell Lymphoma | Phase 1 | Status: RECRUITING